International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Lizi Jiaohuan Yu Xifu/Ion Exchange and Adsorption Fa yi xue za zhi Dianzi Yu Xinxi Xuebao/Journal of Electronics and Information Technology Research Journal of Chemistry and Environment

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-22-07-2020-546
Total View : 438

Abstract : According to Riskesdas (2013), the proportion of population> 15 years who experience hypercholesterolemia is 35.9%. Lestari S research (2016) shows that of 17 people with hypercholesterolemia, 13 (46.4%) have less fiber intake, and 10 (41.7%) have less antioxidant intake. Fermented Glutinous Black Rice and Soy Flour Ice Cream Products that are rich in protein, isoflavones, fiber, and anthocyanins are needed to help reduce blood cholesterol levels which have been proven by several studies to be used as antihypercholesterolemia. This study aims to determine the best formulation of products, data formulation of Fermented Glutinous Black Rice and soy flour, the effect of differences in ice cream formulation on the color, aroma, taste, and texture of the product, as well as knowing the levels of protein, isoflavones, fiber, and anthocyanins of the best formulation product. Design an experimental study research with a Completely Randomized Design (CRD). The research method uses hedonic tests to determine organoleptic properties, kjeldahl for protein testing, literature studies for isoflavone testing, enzymatic gravimetry for fiber testing, and differential pH for anthocyanin tests carried out in February to March 2020. The research was conducted at the Laboratory of Food Technology and Test Organoleptic Laboratory of Poltekkes Bandung, Food Technology Laboratory of Pasundan University, and Testing Laboratory of Bogor Agro Industry Center. Ice cream formulations were obtained from the calculation results, the Formula of Fermented Glutinous Black Rice: soybean flour F1 (85%: 15%), F2 (50%: 50%), F3 (40%: 60%). Kruskal Wallis test results showed there were significant differences in the hedonic test of color and taste. F1 excels at aspects of color, aroma, taste, and texture. It is hoped that further research will be conducted on the effect of giving Fermented Glutinous Black Rice and Soy Flour Ice Cream to samples with blood cholesterol levels above normal.
Full article
International Medical Journal
Journal ID : IMJ-22-07-2020-545
Total View : 408

Abstract : Dyslipidemia in Indonesia is one of major health issues. Some examples such as figures from Central Bogor sub-district in the city of Bogor, West Java, Indonesia, showed that the proportion of lipid profile was quite large, i.e. LDL (80.3%), HDL (56.2%), total cholesterol (49%), and triglyceride (18.5%). Data retrieved from 2013 Basic Health Research also showed that dyslipidemia occurred at any age starting 15 years and older in urban and rural areas (39.5% vs. 32.1% respectively), while hypertriglyceridemia reached 13%. Fermented glutinous black rice (FGBR) has been proven to improve metabolic disorder indices, due to its rich content of antioxidant and fibres. In this study we modified FBGR into a snack bar for dyslipidemia intervention. To assess the efficacy of FGBR snack as a high antioxidant and fiber to improve lipid profile in dyslipidemia patients. A randomised control trial was conducted to assess the efficacy of FBGR snack containing high antioxidant, which is low in glucose but rich in fibre. Samples in this study were 52 adults who were dyslipidemia. Allocation into treatment groups and control group were made equal. Data was obtained from interviews, and blood tests were performed before and after intervention using independent t-test analysis. The results of the study showed that there were significant differences of efficacy in FGBR snack bar consumption to reduce the total cholesterol (p=0.003), triglyceride (p<0.001), LDL Cholesterol (p=0.002), and HDL cholesterol (p<0.001). There were significant differences of efficacy of FGBR snack bar to improve lipid profile. Therefore, FBGR snack bar has the potential to improve dyslipidemia condition.
Full article
International Medical Journal
Journal ID : IMJ-22-07-2020-544
Total View : 411

Abstract : Chronic kidney disease is a global public health issue in the world. In recent years, researchers have begun to attach great importance to new predictors of chronic kidney disease and formation of cardiovascular complications as fibroblast growth factor 23 (FGF-23) and Klotho protein. This article discusses the established average values and reference intervals of Klotho protein in practically healthy people. These intervals can be applied as reference values in research institutions located on the territory of the Republic of Kazakhstan.
Full article
International Medical Journal
Journal ID : IMJ-21-07-2020-543
Total View : 444

Abstract : Minimum intervention dentistry has become a field of great interest in modern restorative dentistry. Preserving tooth structure is critical for the longevity of teeth and restorations. Therefore, various defect-oriented restorations have evolved. Loss of tooth structure may be due to caries or non-carious lesions such as tooth wear. An increasing number of patients visit dental offices with tooth wear. The main problem in case of tooth wear is usually related to occlusal surfaces. In the past, treatment of such patients typically required full crown preparations, with significant loss of sound dental tissue. Another classic indication of full crowns is the need for cuspal coverage. The development of new technologies, dental materials and adhesives has made minimally invasive alternative restorations possible while facilitating tissue preservation. According the literature; cuspal coverage and restoration of occlusal surfaces can be obtained with these minimally invasive alternative restorations. Many names have been described for these full crown alternative restorations which make their understanding and selection may be confusing for dental students, dentists and dental technicians. The purpose of this article is to a) summarize these restorations that may compete the full crowns so that they are kept into the minds of dentists when a tooth is planned to receive cuspal coverage. b) suggest a classification of these new group of restorations for educational purposes c) link different names for the same restoration described in the literature.
Full article
International Medical Journal
Journal ID : IMJ-20-07-2020-542
Total View : 335

Abstract : Hepatic encephalopathy (HE) is a serious complication of liver cirrhosis with a great socioeconomic impact, which impairs the quality of life of patients. Non-absorbable disaccharides and rifaximin are the most commonly used treatments along with the correction of precipitating factors. There are few randomized-controlled trials and many of the current treatment recommendations are based on clinical practice. Rifaximin should start during an episode of HE if there is no clinical improvement after 24-48 hours of non-absorbable disaccharides therapy. Rifaximin as an add-on therapy to lactulose is prudent in recurrent HE in patients who develop a new episode. Rifaximin has proven an effective treatment option for overt HE and in the prevention of recurrence.
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//